What is the generic name?

EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

What is the Trade Name for EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE?

Synjardy

What are the Indications for EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE?

• 1 INDICATIONS AND USAGE SYNJARDY is a combination of empagliflozin and metformin hydrochloride (HCl) indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus . Empagliflozin is indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease [see Clinical Studies (14) ] . SYNJARDY is a combination of empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor and metformin hydrochloride (HCl), a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Empagliflozin is indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease. ( 1 ) Limitation of Use : Not recommended in patients with type 1 diabetes mellitus. It may increase the risk of diabetic ketoacidosis in these patients. ( 1 ) Limitation of Use SYNJARDY is not recommended in patients with type 1 diabetes mellitus. It may increase the risk of diabetic ketoacidosis in these patients [see Warnings and Precautions (5.2) ] .

References: https://open.fda.gov/